Skip to main content
Premium Trial:

Request an Annual Quote

Galapagos to Buy DPI s Drug-Discovery Service Arm for $5.4M

NEW YORK, June 13 (GenomeWeb News) - Galapagos will acquire the entire drug-discovery service operation of Discovery Partners International for €4.25 million ($5.4 million) in cash, the companies said today.

Under the terms of the agreement, Galapagos will acquire all of the outstanding capital stock or equity interests of DPI subsidiaries Discovery Partners International, ChemRx Advanced Technologies, Xenometrix, and Discovery Partners International, as well as certain contracts connection with the transaction.

Galapagos, headquartered in Mechelen, Belgium, will inherit DPI's four service sites located in San Diegoand South San Francisco, Calif., Basel,Switzerland, and Heidelberg, Germany; as well as DPI's Japanese sales office in Tokyo.

The companies anticipate layoffs of general and administrative staff in the San Diegofacility, but expect all four of the DPI services locations to remain fully operational. There are approximately 100 people employed at the acquired sites, which will bring the total Galapagos headcount to more than 320, the companies said.

 

Galapagos also said that it will merge the service sites into BioFocus, its drug-discovery services division, and, as a result, will change the name of the division to BioFocus DPI.

 

Galapagos anticipates that DPI operations will contribute more than €8 million in external revenues to BioFocus DPI for the six months remaining in 2006. Major 2006 customers for these operations include Actelion, Allergan, Biovitrum, GlaxoSmithKline, Mitsubishi Pharma, thr US National Institutes of Health, Novartis, and Ono, the companies said.

 

The transaction is subject to customary closing conditions and is expected to close in July, the companies said.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.